Deutsche Bank
INDP icon

Deutsche Bank’s Indaptus Therapeutics INDP Stock Holding History

Deutsche Bank’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-32
Closed -$308K – 5077
2019
Q2 		$308K Buy
+32
New +$404K ﹤0.01% 3576
2018
Q4 		– Sell
-18
Closed -$225K – 5266
2018
Q3 		$225K Sell
18
-21
-54% -$200K ﹤0.01% 4186
2018
Q2 		$389K Buy
39
+32
+457% +$355K ﹤0.01% 3974
2018
Q1 		$95K Sell
7
-44
-86% -$624K ﹤0.01% 4523
2017
Q4 		$593K Buy
51
+19
+59% +$294K ﹤0.01% 3515
2017
Q3 		$647K Buy
32
+21
+191% +$303K ﹤0.01% 3283
2017
Q2 		$145K Buy
11
+5
+83% +$60.7K ﹤0.01% 4074
2017
Q1 		$65K Buy
6
+1
+20% +$11.1K ﹤0.01% 4116
2016
Q4 		$63K Sell
5
-5
-50% -$58.4K ﹤0.01% 4278
2016
Q3 		$126K Buy
+10
New +$124K ﹤0.01% 3854

Other funds holding INDP

MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Deutsche Bank's INDP Position: Q3 2019 in Review

Deutsche Bank sold out of Indaptus Therapeutics (INDP) in Q3 2019, closing a stake of 32 shares — an estimated $308K sold.

Deutsche Bank first reported a position in INDP in Q3 2016 and held it in 10 quarters. The position peaked at $647K in Q3 2017. 33 funds tracked by Wall St. Rank hold INDP as of Q3 2019.

  • Deutsche Bank reported no remaining Indaptus Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Deutsche Bank sold 32 Indaptus Therapeutics shares in Q3 2019, an estimated $308K.
  • Deutsche Bank first reported a position in Indaptus Therapeutics in Q3 2016 and held it in 10 quarters.
  • Deutsche Bank's Indaptus Therapeutics position peaked at $647K in Q3 2017.
  • 33 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2019.

Based on Deutsche Bank's 13F filing for Q3 2019, filed 14 Nov 2019.